4//SEC Filing
Shukla Sath 4
Accession 0000950170-23-037973
CIK 0001701108other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:10 PM ET
Size
4.9 KB
Accession
0000950170-23-037973
Insider Transaction Report
Form 4
Shukla Sath
CEO & President
Transactions
- Award
Common Stock
2023-08-01+266,000→ 578,517 total
Footnotes (1)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on August 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001782817
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:10 PM ET
- Size
- 4.9 KB